L. D. Jacobs

1.0k total citations
9 papers, 513 citations indexed

About

L. D. Jacobs is a scholar working on Pathology and Forensic Medicine, Immunology and Psychiatry and Mental health. According to data from OpenAlex, L. D. Jacobs has authored 9 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Immunology and 3 papers in Psychiatry and Mental health. Recurrent topics in L. D. Jacobs's work include Migraine and Headache Studies (2 papers), Dental Anxiety and Anesthesia Techniques (2 papers) and Multiple Sclerosis Research Studies (2 papers). L. D. Jacobs is often cited by papers focused on Migraine and Headache Studies (2 papers), Dental Anxiety and Anesthesia Techniques (2 papers) and Multiple Sclerosis Research Studies (2 papers). L. D. Jacobs collaborates with scholars based in Netherlands, United States and Sweden. L. D. Jacobs's co-authors include Donald E. Goodkin, A. Le Liboux, Björn Engström, J R Richert, Amy M. Salazar, Diane L. Cookfair, R. A. Rudick, M. Campion, Nancy A. Simonian and W. E. Jones and has published in prestigious journals such as Neurology, Lara D. Veeken and British Journal of Clinical Pharmacology.

In The Last Decade

L. D. Jacobs

9 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. D. Jacobs Netherlands	8	270	152	106	97	96	9	513
Agnès Fromont France	11	430 1.6×	143 0.9×	84 0.8×	194 2.0×	85 0.9×	30	809
Rachel Farrell United Kingdom	14	359 1.3×	143 0.9×	164 1.5×	136 1.4×	160 1.7×	44	755
Seyed-Hossein Abtahi Iran	14	282 1.0×	57 0.4×	36 0.3×	109 1.1×	44 0.5×	50	698
Madalina Chirieac United States	7	277 1.0×	73 0.5×	105 1.0×	111 1.1×	90 0.9×	12	504
Elaine Regina Delicato de Almeida Brazil	12	238 0.9×	86 0.6×	62 0.6×	66 0.7×	83 0.9×	24	482
Maddalena Alessandra Wu Italy	13	173 0.6×	191 1.3×	43 0.4×	25 0.3×	106 1.1×	55	694
Bijal Mehta United States	10	188 0.7×	77 0.5×	30 0.3×	81 0.8×	58 0.6×	35	410
Olga Carmona Spain	12	277 1.0×	55 0.4×	62 0.6×	104 1.1×	23 0.2×	30	438
Johana Béné France	12	194 0.7×	168 1.1×	64 0.6×	16 0.2×	67 0.7×	34	591
Po–Jung Pan Taiwan	14	53 0.2×	30 0.2×	47 0.4×	91 0.9×	31 0.3×	32	535

Countries citing papers authored by L. D. Jacobs

Since Specialization

Citations

This map shows the geographic impact of L. D. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. D. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. D. Jacobs more than expected).

Fields of papers citing papers by L. D. Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. D. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. D. Jacobs. The network helps show where L. D. Jacobs may publish in the future.

Co-authorship network of co-authors of L. D. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of L. D. Jacobs. A scholar is included among the top collaborators of L. D. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. D. Jacobs. L. D. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Goodkin, Donald E., J L Winkelhake, Emmanuelle Waubant, et al.. (2000). A phase I trial of solubilized DR2:MBP ^84-102 (AG284) in multiple sclerosis. Neurology. 54(7). 1414–1420. 50 indexed citations

2.

Rolf, Christer, et al.. (1999). Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Lara D. Veeken. 38(6). 564–567. 69 indexed citations

3.

Rudick, R. A., Nancy A. Simonian, Jehan Alam, et al.. (1998). Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Neurology. 50(5). 1266–1272. 262 indexed citations

4.

Rolf, Christer, et al.. (1997). An open, randomized study of ketoprofen in patients in surgery for Achilles or patellar tendinopathy.. PubMed. 24(8). 1595–8. 25 indexed citations

5.

Gerven, Joop van, et al.. (1996). Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary. British Journal of Clinical Pharmacology. 42(4). 475–481. 32 indexed citations

6.

Gerven, Joop van, et al.. (1996). Self‐medication of a single headache episode with ketoprofen, ibuprofen or placebo, home‐monitored with an electronic patient diary. British Journal of Clinical Pharmacology. 42(4). 475–481. 26 indexed citations

7.

Kuyk, Jarl, et al.. (1995). Pseudo-epileptic seizures: Hypnosis as a diagnostic tool. Seizure. 4(2). 123–128. 25 indexed citations

8.

Jacobs, L. D., et al.. (1994). Results of a phase III trial of IM recombinant beta interferon as treatment for MS. Journal of Neuroimmunology. 54(1-2). 170–170. 5 indexed citations

9.

Bakshi, R., et al.. (1992). A double-blind, placebo-controlled trial comparing the analgesic efficacy of two formulations of diclofenac in postoperative dental pain. Current Therapeutic Research. 52(3). 435–442. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact